title: Effect of PRL on MAPK activation: negative regulatory role of the C-terminal part of the PRL receptor.
abstract: Prolactin induces cell proliferation and cell differentiation through well-known MAPK Erk, and JAK2/STAT5 pathways depending on the cell line. The aim of the present study was to delineate the functional domains of the PRL receptor involved in PRL induced MAPK regulation. Using various PRL-R mutants of the cytoplasmic domain we found, that the membrane proximal domain is necessary for PRL induced MAPK activation and that the C-terminal part of the receptor exerts a negative regulatory role. A pharmacological approach, using different types of inhibitors, provided evidence that PRL induced MAPK activation requires both a MEK dependent pathway and a PI3K dependent pathway. The negative regulation induced by the carboxy-terminal part of the receptor involves a combination of tyrosine phosphatases and serine/threonine phosphatases as concluded from the actions of the phosphatase inhibitors: pervanadate, PAO and okadaic acid. The mechanism by which these phosphatases are recruited or are induced by the last 141 cytoplasmic residues of the receptor remains to be determined. Finally the negative regulatory role of the carboxy-terminal part of the receptor, first demonstrated in the present study, is discussed in terms of the regulation of different effects of PRL on growth and differentiation.
authors.affiliation: Unité d'Endocrinologie Moléculaire, I.N.R.A., Jouy en Josas, France.
authors.forename: O
authors.initials: O
authors.lastname: Goupille
authors.forename: J V
authors.initials: JV
authors.lastname: Barnier
authors.forename: B
authors.initials: B
authors.lastname: Guibert
authors.forename: J
authors.initials: J
authors.lastname: Paly
authors.forename: J
authors.initials: J
authors.lastname: Djiane
mesh_terms: D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D011388:Prolactin / Q000494:pharmacology*; D017434:Protein Structure, Tertiary; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors; D011817:Rabbits; D011981:Receptors, Prolactin / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D017384:Sequence Deletion
chemical_list: D004791:Enzyme Inhibitors; D011981:Receptors, Prolactin; D011388:Prolactin; D020928:Mitogen-Activated Protein Kinases; D010749:Phosphoprotein Phosphatases; D017027:Protein Tyrosine Phosphatases